Page 20 - நாள்பட்ட ஜூலியார்ட் பெயர் சொட்டு மருந்து ட்ரெண்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நாள்பட்ட ஜூலியார்ட் பெயர் சொட்டு மருந்து ட்ரெண்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நாள்பட்ட ஜூலியார்ட் பெயர் சொட்டு மருந்து ட்ரெண்ட் Today - Breaking & Trending Today

Study indicates neural pathway that provides pain relief, reduces cravings for opioids


Study indicates neural pathway that provides pain relief, reduces cravings for opioids
Researchers have discovered that there may be a new pathway in the brain that provides pain relief and reduces cravings for opioids.
Over a third of the U.S. population suffers from chronic pain, with little to no reported relief from medication. Transcranial magnetic brain stimulation (TMS) is a noninvasive form of brain stimulation that may offer a new treatment option for these underserved members of our community.
In a recent paper in
Drug and Alcohol Dependence, researchers at the Medical University of South Carolina evaluated two different strategies for relieving pain with TMS: applying TMS to the motor cortex and the dorsolateral prefrontal cortex (DLPFC). ....

Colleen Hanlon , Julia Imperatore , Emily Henderson , Wake Forest School Of Medicine , University Of South Carolina , Department Of Psychiatry , Alcohol Dependence , Medical University , South Carolina , Principal Investigator , Wake Forest School , Brain Stimulation , Chronic Pain , Magnetic Brain Stimulation , சக ஹன்லான் , எமிலி ஹென்டர்சன் , எழுந்திரு காடு பள்ளி ஆஃப் மருந்து , பல்கலைக்கழகம் ஆஃப் தெற்கு கரோலினா , துறை ஆஃப் மனநல மருத்துவம் , ஆல்கஹால் சார்பு , மருத்துவ பல்கலைக்கழகம் , தெற்கு கரோலினா , ப்ரிந்ஸிபல் புலனாய்வாளர் , எழுந்திரு காடு பள்ளி , மூளை ஸ்டிம்யுலேஶந் , நாள்பட்ட வலி ,

Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease


Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease
Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.
The Canadian research team was the first to use gene therapy in 2017 to treat patients with Fabry disease, a rare, chronic illness that can damage major organs and shorten lives. They report their findings today in the journal
Nature Communications.
Being one of the first people in the world to receive this treatment, and seeing how much better I felt afterward, it definitely gives me hope that this can help many other Fabry patients and potentially those with other single gene mutation disorders, says Ryan Deveau, one of the participating patients in Dartmouth, Nova Scotia. Now that I don t have to get the replacement therapy every two weeks, I have more time to spend with my family. ....

Stephen Couban , Darren Bidulka , Aneal Khan , Ryan Deveau , Michael West , Emily Henderson , University Health Network , Nature Communications , Alberta Health Service Foothills Medical Centre , Cumming School Of Medicine , Nova Scotia Health , National Institutes Of Health , Alberta Health Services , College Of Wisconsin , Princess Margaret Cancer Centre , Fund Professor , University Of Calgary , Health Canada , Alberta Children Hospital Research Institute , Alberta Children , Hospital Research Institute , Cumming School , Queen Elizabeth , Sciences Centre , Jeffrey Medin , Senior Scientist ,

Study reveals new routes to potential treatments for chronic inflammatory conditions


Study reveals new routes to potential treatments for chronic inflammatory conditions
Inflammatory lung diseases such as asthma, COPD and, most recently, COVID-19, have proven difficult to treat. Current therapies reduce symptoms and do little to stop such diseases from continuing to damage the lungs. Much research into treating chronic inflammatory diseases has focused on blocking chemicals called cytokines, which trigger cascades of molecular events that fuel damaging inflammation.
Now, scientists at Washington University School of Medicine in St. Louis have found that such cytokines can drive inflammation in more ways than previously understood, perhaps revealing new routes to potential treatments for chronic inflammatory conditions. ....

Michaelj Holtzman , Jennifer Alexander Brett , Emily Henderson , Division Of Pulmonary , Washington University , Washington University School Of Medicine , Washington University School , Critical Care , Herman Seldin Professor , Lung Disease , Inflammatory Disease , ஜெனிபர் அலெக்சாண்டர் ப்ரெட் , எமிலி ஹென்டர்சன் , பிரிவு ஆஃப் நுரையீரல் , வாஷிங்டன் பல்கலைக்கழகம் , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி , முக்கியமான பராமரிப்பு , ஹெர்மன் செல்தின் ப்ரொஃபெஸர் , நுரையீரல் நோய் , அழற்சி நோய் ,